Search research articles
Contact Us
Filters
Showing results (251-260 of 277) with videos related to
Page
of 28
Sort By:
Journal of Neurochemistry
|
October 1, 1990
Determination of gangliosides in six human primary medulloblastomas
J Gottfries, P Fredman, J E Månsson, et al.
Journal of Neuropathology and Experimental Neurology
|
January 1, 1989
Phenotypic analysis of four human medulloblastoma cell lines and transplantable xenografts
X M He, S X Skapek, C J Wikstrand, et al.
Cancer Research
|
October 1, 1995
Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts
C J Reist, G E Archer, S N Kurpad, et al.
Cancer
|
May 4, 2001
Long term response in a patient with neoplastic meningitis secondary to melanoma treated with (131)I-radiolabeled antichondroitin proteoglycan sulfate Mel-14 F(ab')(2): a case study
I Cokgor, G Akabani, H S Friedman, et al.
Journal of Neuro-Oncology
|
July 10, 2009
Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors
Weilian Yang, Rolf F Barth, Gong Wu, et al.
Journal of Internal Medicine
|
January 4, 2012
The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*
S H Nymo, T Ueland, E T Askevold, et al.
Journal of Neuroimmunology
|
May 1, 1987
Comparative localization of glioma-reactive monoclonal antibodies in vivo in an athymic mouse human glioma xenograft model
C J Wikstrand, R E McLendon, S Carrel, et al.
Cancer Research
|
July 15, 1995
Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas
C J Wikstrand, L P Hale, S K Batra, et al.
Journal of Neuro-Oncology
|
January 1, 1995
Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report
D D Bigner, M Brown, R E Coleman, et al.
Cancer Research
|
March 1, 1992
Expression of O6-methylguanine-DNA methyltransferase in six human medulloblastoma cell lines
X M He, L E Ostrowski, M A von Wronski, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 277) with videos related to
Sort By:
Page
of 28
Journal of Neurochemistry
|
October 1, 1990
Determination of gangliosides in six human primary medulloblastomas
J Gottfries, P Fredman, J E Månsson, et al.
Journal of Neuropathology and Experimental Neurology
|
January 1, 1989
Phenotypic analysis of four human medulloblastoma cell lines and transplantable xenografts
X M He, S X Skapek, C J Wikstrand, et al.
Cancer Research
|
October 1, 1995
Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts
C J Reist, G E Archer, S N Kurpad, et al.
Cancer
|
May 4, 2001
Long term response in a patient with neoplastic meningitis secondary to melanoma treated with (131)I-radiolabeled antichondroitin proteoglycan sulfate Mel-14 F(ab')(2): a case study
I Cokgor, G Akabani, H S Friedman, et al.
Journal of Neuro-Oncology
|
July 10, 2009
Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors
Weilian Yang, Rolf F Barth, Gong Wu, et al.
Journal of Internal Medicine
|
January 4, 2012
The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*
S H Nymo, T Ueland, E T Askevold, et al.
Journal of Neuroimmunology
|
May 1, 1987
Comparative localization of glioma-reactive monoclonal antibodies in vivo in an athymic mouse human glioma xenograft model
C J Wikstrand, R E McLendon, S Carrel, et al.
Cancer Research
|
July 15, 1995
Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas
C J Wikstrand, L P Hale, S K Batra, et al.
Journal of Neuro-Oncology
|
January 1, 1995
Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report
D D Bigner, M Brown, R E Coleman, et al.
Cancer Research
|
March 1, 1992
Expression of O6-methylguanine-DNA methyltransferase in six human medulloblastoma cell lines
X M He, L E Ostrowski, M A von Wronski, et al.
Page
of 28